Nishant Sethi, MD
Interventional Cardiology · Scranton, PANPI 1306070735
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $835,656 of the $1,335,809 with a category attached, or 62.6%. Medtronic accounts for 75.3% of it on its own, with 31 other manufacturers making up the rest. Among interventional cardiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,667 payments — averaging $801.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1M
- Abbott$232K
- Edwards Lifesciences$76K
- Bard Peripheral Vascular, Inc.$14K
- Boston Scientific$4K
- Abiomed$1K
- plus $4K from 26 others
What the payments were for
- Consulting fees$168,93813%
- Speaking & faculty fees$835,65663%
- Travel & lodging$286,69921%
- Food & beverage$44,3613%
- Education$870%
- Other$680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 1,017 | $1,005,370 |
| Abbott | 202 | $231,897 |
| Edwards Lifesciences | 193 | $75,512 |
| Bard Peripheral Vascular, Inc. | 13 | $13,744 |
| Boston Scientific | 74 | $4,011 |
| Abiomed | 19 | $1,131 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $1,010 |
| E.r. Squibb & Sons, L.L.C. | 28 | $739 |
| Novartis | 48 | $712 |
| Shockwave Medical, Inc | 10 | $343 |
| Pfizer | 14 | $271 |
| Gentuity, LLC | 1 | $151 |
| Penumbra, Inc. | 1 | $129 |
| Teleflex LLC | 1 | $122 |
| Getinge USA Sales, LLC | 2 | $78 |
| Inari Medical, Inc. | 5 | $76 |
| Baxter Healthcare | 1 | $68 |
| Johnson & Johnson | 4 | $61 |
| AstraZeneca | 3 | $54 |
| Merck | 2 | $44 |
| Scpharmaceuticals Inc. | 1 | $40 |
| Philips North America LLC | 1 | $36 |
| Terumo Medical Corporation | 2 | $33 |
| Bayer | 2 | $33 |
| Novo Nordisk | 2 | $30 |
| Acist Medical Systems, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $20 |
| Imperative Care, Inc | 1 | $17 |
| Bridgebio Pharma, Inc. | 1 | $15 |
| Braemar Manufacturing, LLC | 1 | $14 |
| Lantheus Medical Imaging, Inc. | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$494,396
- COREVALVE EVOLUT R$484,126
- NAVITOR$226,899
- Edwards SAPIEN 3 Transcatheter Heart Valve$63,102
- RESOLUTE ONYX$12,167
- PASCAL$3,156
- XIENCE V$1,706
- SAPIEN 3 Ultra RESILIA$1,634
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,414
- ONYX FRONTIER$1,230
- AVVIGO Guidance System$1,007
- Fluency Endovascular Stent Graft$612
- VenaSeal$589
- OPTIS$553
- Impella$342
- PORTICO$306
- CAMZYOS$259
- WATCHMAN Access System$224
- TRUE FLOW$220
- Mitra Clip system$175
How this compares
$1,335,809 in reported general payments places this provider in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 172 | $144,487 |
| EntrestoSacubitril/Valsartan | 92 | $93,510 |
| XareltoRivaroxaban | 16 | $14,955 |
| BrilintaTicagrelor | 13 | $10,604 |
| Metoprolol Succinate | 234 | $3,590 |
| ClopidogrelClopidogrel Bisulfate | 375 | $3,057 |
| Atorvastatin Calcium | 226 | $2,493 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 94 | $1,732 |
| Warfarin Sodium | 89 | $1,517 |
| Rosuvastatin Calcium | 79 | $1,412 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 60 | $1,408 |
| Carvedilol | 82 | $1,156 |
| Amlodipine Besylate | 105 | $803 |
| Ezetimibe | 40 | $745 |
| Pantoprazole Sodium | 41 | $713 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $271 | $144,487172 claims |
| NovartisEntresto | $712 | $93,51092 claims |
| Johnson & JohnsonXarelto | $61 | $14,95516 claims |
| AstraZenecaBrilinta | $54 | $10,60413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.
Other interventional cardiology in Scranton
- Deepika KalisettiScranton$30K
- Matthew BeckerErie$1M
- William GrayWynnewood$753K
- Jon GeorgePhiladelphia$637K
- Shailendra SinghAllentown$470K
- Sanjog KalraPhiladelphia$444K
- James HarveyChambersburg$442K
- Taisei KobayashiPhiladelphia$384K
- Antonis PratsosBroomall$377K
- Ronald FieldsNew Hope$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.